XML 22 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 5 - Investments (Details) (USD $)
12 Months Ended 42 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Note 5 - Investments (Details) [Line Items]      
Proceeds from Issuance of Common Stock $ 4,368,000 $ 1,122,000 $ 8,008,000
Immune Pharmaceuticals Ltd. [Member]
     
Note 5 - Investments (Details) [Line Items]      
Sale of Stock, Number of Shares Issued in Transaction (in Shares) 3,846,154    
Sale of Stock, Price Per Share (in Dollars per share) $ 0.13   $ 0.13
Proceeds from Issuance of Common Stock 500,000    
Proceeds from Related Party Debt $ 1,100,000    
Related Party Transaction, Rate 3.27%